Articles related to Surgery, Orthopedic
Metastatic Bone Disease: Early Referral for Multidisciplinary Care
Explore the multidisciplinary approach to bone metastasis management, emphasizing early detection, proactive intervention, and the significant role of primary care providers in this process.
Internal Medicine July 25th 2023
From ER to OR: Reducing Admissions in Appendicitis and Cholecystitis
Discover how an ER-to-OR pathway can effectively reduce inpatient admissions and lower treatment costs, particularly during times of healthcare system stress, in this detailed study analysis.
Emergency Medicine July 20th 2023
Dopamine-antagonist Antiemetics in PONV Management: Entering a New Era?
The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.
Anesthesiology July 20th 2023
Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
This in-depth research opens up potential avenues for the use of ADMSCs in managing K-L grade 3 knee osteoarthritis, particularly in terms of pain and functional improvements, signifying a promising frontier in osteoarthritis treatment.
Surgery, Orthopedic July 12th 2023
Association of Low-Dose Colchicine with Incidence of Knee and Hip Replacements
A Randomized, Controlled, Double-Blind Trial Analyzing Colchicine’s Role in Reducing Knee and Hip Replacement Incidences An exploratory analysis of the LoDoCo2 randomized trial has led to a promising correlation between low-dose colchicine treatment and a reduced incidence of knee and hip replacements.
Family Medicine/General Practice June 6th 2023
Hidden Drugs Found in 3 Supplements Promoted for Joint Pain, Arthritis
FDA Cautions Against Hidden Drug Ingredients in Joint Pain Supplements In response to recent findings, the FDA warns of significant health risks associated with three specific dietary supplements marketed for joint pain and rheumatoid arthritis relief due to the discovery of unlisted active pharmaceutical ingredients.
Anesthesiology June 6th 2023